August 2012
-
Jan De Backer, CEO of Antwerp-based FluidDA, calculates that the combination of biomedical imaging and computational fluid dynamics offered by his company has the potential to reduce development costs for OINDPs by hundreds of millions… Read more . . .
-
Aptar Pharma is touting the use of its “Classic” modular spray pump in the recently launched Sprix ketorolac tromethamine nasal spray from Regency Therapeutics. Regency is a new division of Luitpold Pharmaceuticals, which acquired Sprix… Read more . . .
-
Generex Biotechnology has reached an agreement with Amarantus BioSciences regarding Generex’s RapidMist buccal aerosol delivery system. The RapidMist device is a modified metered dose inhaler that delivers the aerosol to the lining of the mouth… Read more . . .
-
Rigel Pharmaceuticals has said that it is raising approximately $130.4 million as the result of a stock offering involving 16.3 million new shares. The company says that it expects the offer to close on or… Read more . . .
-
MAP Pharmaceuticals has submitted a new drug application (NDA) to the US FDA for its Levadex inhaled dihydroergotamine (DHE) for the treatment of migraines. The delivery device used for the product is the company’s proprietary… Read more . . .
-
Cirrus Pharmaceuticals, Inc. is seeking a B.S./M.S. level scientist with dry powder inhaler (DPI) expertise. The candidate should have several years of pharma experience performing DPI pre-formulation, formulation development, and aerosol characterization work. Experience in… Read more . . .
-
Members of the Committee for Medicinal Products for Human Use (CHMP) have indicated that they would vote against approval of Pharmaxis’s marketing application for Bronchitol as a treatment for cystic fibrosis (CF). The CHMP took… Read more . . .
-
OptiNose has won the Oslo regional competition of the DnB NOR Innovation Award for its nasal drug delivery technology, and the company will compete in the Norwegian national competition in September. The regional award includes… Read more . . .
-
At the end of the 2011 RDD Europe conference in Berlin, co-organizers RDD Online and Aptar Pharma announced that the next RDD Europe meeting will take place in Athens, Greece at the Athens Hilton Hotel,… Read more . . .
-
The FDA has announced a shortage of acetylcysteine inhalation solution in the US due to increased demand and manufacturing delays. Acetylcysteine is a mucolytic agent. According to the FDA web site, two manufacturers, Hospira and… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.